Display options
Cite
Kuzmenkov AY, Trushin IV, Vinogradova AG, et al. AMRmap: An Interactive Web Platform for Analysis of Antimicrobial Resistance Surveillance Data in Russia. Front Microbiol. 2021;12:620002doi: 10.3389/fmicb.2021.620002.
Kuzmenkov, A. Y., Trushin, I. V., Vinogradova, A. G., Avramenko, A. A., Sukhorukova, M. V., Malhotra-Kumar, S., Dekhnich, A. V., Edelstein, M. V., & Kozlov, R. S. (2021). AMRmap: An Interactive Web Platform for Analysis of Antimicrobial Resistance Surveillance Data in Russia. Frontiers in microbiology, 12620002. https://doi.org/10.3389/fmicb.2021.620002
Kuzmenkov, Alexey Y, et al. "AMRmap: An Interactive Web Platform for Analysis of Antimicrobial Resistance Surveillance Data in Russia." Frontiers in microbiology vol. 12 (2021): 620002. doi: https://doi.org/10.3389/fmicb.2021.620002
Kuzmenkov AY, Trushin IV, Vinogradova AG, Avramenko AA, Sukhorukova MV, Malhotra-Kumar S, Dekhnich AV, Edelstein MV, Kozlov RS. AMRmap: An Interactive Web Platform for Analysis of Antimicrobial Resistance Surveillance Data in Russia. Front Microbiol. 2021 Mar 12;12:620002. doi: 10.3389/fmicb.2021.620002. eCollection 2021. PMID: 33776956; PMCID: PMC7994358.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2021 Mar 12;12:620002. doi: 10.3389/fmicb.2021.620002. eCollection 2021.

AMRmap: An Interactive Web Platform for Analysis of Antimicrobial Resistance Surveillance Data in Russia.

Frontiers in microbiology

Alexey Y Kuzmenkov, Ivan V Trushin, Alina G Vinogradova, Andrey A Avramenko, Marina V Sukhorukova, Surbhi Malhotra-Kumar, Andrey V Dekhnich, Mikhail V Edelstein, Roman S Kozlov

Affiliations

  1. Institute of Antimicrobial Chemotherapy, Smolensk State Medical University of the Ministry of Health of the Russian Federation, Smolensk, Russia.
  2. Department of Medical Microbiology, University of Antwerp, Antwerp, Belgium.

PMID: 33776956 PMCID: PMC7994358 DOI: 10.3389/fmicb.2021.620002

Abstract

Surveillance of antimicrobial resistance (AMR) is crucial for identifying trends in resistance and developing strategies for prevention and treatment of infections. Globally, AMR surveillance systems differ in terms of organizational principles, comprehensiveness, accessibility, and usability of data presentation. Until recently, the data on AMR in Russia were scarcely available, especially to international community, despite the fact that the large prospective multicenter surveillance in Russia was conducted and data were accumulated for over 20 years. We describe the source of data, structure, and functionality of a new-generation web platform, called AMRmap (https://amrmap.net/), for analysis of AMR surveillance data in Russia. The developed platform currently comprises susceptibility data of >40,000 clinical isolates, and the data on abundance of key resistance determinants, including acquired carbapenemases in gram-negatives, are updated annually with information on >5,000 new isolates. The AMRmap allows smart data filtration by multiple parameters and provides interactive data analysis and visualization tools: MIC and S/I/R distribution plots, time-trends and regression plots, associated resistance plots, prevalence maps, statistical significance graphs, and tables.

Copyright © 2021 Kuzmenkov, Trushin, Vinogradova, Avramenko, Sukhorukova, Malhotra-Kumar, Dekhnich, Edelstein and Kozlov.

Keywords: AMRmap; antimicrobial drugs; antimicrobial resistance; data analysis; surveillance

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Chemother. 2005 Feb;17(1):54-60 - PubMed
  2. J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii15-28 - PubMed
  3. Front Microbiol. 2016 Mar 08;7:294 - PubMed
  4. Antimicrob Agents Chemother. 2002 Sep;46(9):2963-8 - PubMed
  5. Clin Microbiol Infect. 2004 Apr;10(4):349-83 - PubMed
  6. Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S4-9 - PubMed
  7. Am J Infect Control. 2008 Jun;36(5):309-32 - PubMed
  8. Lancet Infect Dis. 2013 Oct;13(10):867-76 - PubMed

Publication Types